title: Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation.
authors: Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA.
authors: V
authors: V
authors: Roy
authors: Hematology, Mayo Clinic, Scottsdale, AZ, USA.
authors: A K
authors: AK
authors: Stewart
authors: Hematology, Mayo Clinic, Scottsdale, AZ, USA.
authors: P L
authors: PL
authors: Bergsagel
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: A
authors: A
authors: Dispenzieri
authors: Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
authors: K
authors: K
authors: Laumann
authors: Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
authors: J
authors: J
authors: Allred
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: M Q
authors: MQ
authors: Lacy
authors: Hematology, Mayo Clinic, Scottsdale, AZ, USA.
authors: R
authors: R
authors: Fonseca
authors: Hematology, Mayo Clinic, Scottsdale, AZ, USA.
authors: C B
authors: CB
authors: Reeder
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: S
authors: 0000000153929284
authors: S
authors: Kumar
authors: Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA.
authors: C E
authors: CE
authors: Rivera
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: M A
authors: MA
authors: Gertz
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: F K
authors: FK
authors: Buadi
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: S R
authors: SR
authors: Hayman
authors: Hematology, Mayo Clinic, Rochester, MN, USA.
authors: S V
authors: SV
authors: Rajkumar
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide; D008558:Melphalan; D011241:Prednisone